Diabetic cardiomyopathy

被引：56

作者：

Fonarow, Gregg C.

Srikanthan, Preethi

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson UCLA Cardiomyopathy Ctr, Div Cardiol, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Div Epidemiol & Prevent Med, Los Angeles, CA 90095 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2006年 / 35卷 / 03期

关键词：

D O I：

10.1016/j.ecl.2006.05.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article focuses on advances in the understanding of the pathogenesis and treatment of diabetic cardiomyopathy. Patients with diabetes are at an elevated risk for heart failure, and comorbid heart failure confers an increased risk of morbidity and mortality. Diabetic cardiomyopathy is a distinctive syndrome that also confers high risk. Every effort should be made to diagnose patients with diabetic cardiomyopathy and to apply proven lifesaving therapies in all heart failure patients, including those with diabetes, in the absence of contraindications or intolerance.

引用

页码：575 / +

页数：26

共 101 条

[1] Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats [J].

Abe, T ;

Ohga, Y ;

Tabayashi, N ;

Kobayashi, S ;

Sakata, S ;

Misawa, H ;

Tsuji, T ;

Kohzuki, H ;

Suga, H ;

Taniguchi, S ;

Takaki, M .

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (01) :H138-H148

[2] Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up [J].

Ärnlöv, J ;

Lind, L ;

Zethelius, B ;

Andrén, B ;

Hales, CN ;

Vessby, B ;

Lithell, H .

AMERICAN HEART JOURNAL, 2001, 142 (04) :720-724

[3] Effects of glucose intolerance on myocardial function and collagen-linked glycation [J].

Avendano, GF ;

Agarwal, RK ;

Bashey, RI ;

Lyons, MM ;

Soni, BJ ;

Jyothirmayi, GN ;

Regan, TJ .

DIABETES, 1999, 48 (07) :1443-1447

[4] Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes [J].

Bahr, M ;

Spelleken, M ;

Bock, M ;

vonHoltey, M ;

Kiehn, R ;

Eckel, J .

DIABETOLOGIA, 1996, 39 (07) :766-774

[5] Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension - A randomized controlled trial [J].

Bakris, GL ;

Fonseca, V ;

Katholi, RE ;

McGill, JB ;

Messerli, FH ;

Phillips, RA ;

Raskin, P ;

Wright, JT ;

Oakes, R ;

Lukas, MA ;

Anderson, KM ;

Bell, DSH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (18) :2227-2236

[6] DIABETIC CARDIOMYOPATHY - A UNIQUE ENTITY OR A COMPLICATION OF CORONARY-ARTERY DISEASE [J].

BELL, DSH .

DIABETES CARE, 1995, 18 (05) :708-714

[7] Diabetic cardiomyopathy [J].

Bell, DSH .

DIABETES CARE, 2003, 26 (10) :2949-2951

[8] Diabetes and idiopathic cardiomyopathy - A nationwide case-control study [J].

Bertoni, AG ;

Tsai, A ;

Kasper, EK ;

Brancati, FL .

DIABETES CARE, 2003, 26 (10) :2791-2795

[9] Survival and hospitalization in heart failure patients with or without diabetes treated with β-blockers [J].

Bobbio, M ;

Ferrua, S ;

Opasich, C ;

Porcu, M ;

Lucci, D ;

Scherillo, M ;

Tavazzi, L ;

Maggioni, AP .

JOURNAL OF CARDIAC FAILURE, 2003, 9 (03) :192-202

[10]

BRISTOW MR, 1996, CIRCULATION, V84, pI644

← 1 2 3 4 5 6 7 8 9 10 →